Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 trial of TVAX-008 for chronic hepatitis B
CTR20260929Phase 3Active
- Sponsor
- Sciwind Biosciences
- Start
- Mar 2026
- Modality
- Cancer Vaccines → Therapeutic Vaccines → Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of TVAX-008 in Chronic Hepatitis B (CHB), sponsored by Sciwind Biosciences. Started Mar 2026; status: active.
02
Drugs
TVAX-008
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on CTR20260929.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20260929.